In your peer response, include something new that was learned from reading the SBAR and/or an opinion that differs from that of the author.
The following is my SBAR from Assignment #2. My topic was how the Affordable Care Act affects the transgender community.
The Trump administration has announced plans to reduce important regulations pertaining to Section 1557 of the Affordable Care Act. This section relates to the protection of the transgender community from discrimination in health care and insurance coverage. With a reduction to this regulation, it will still be illegal to discriminate against the transgender population. However, it will increase the difficulty of enforcing one’s rights.
The objective of the Affordable Care Act (ACA) is to make health care accessible and affordable to all Americans, regardless of age, sex, race, color, national origin, or disability. However, transgenders continued to face discrimination in the health care system, as they were not being recognized as a protected entity. A final ruling in 2016, regarding Section 1557, determined that protection against sex discrimination extends to the transgender population.
Under current legislation, the transgender community is protected from health care and insurance coverage discrimination, thus making bias against this population illegal. Reducing their rights, under the present ruling, will hinder their access to appropriate health care and continue to foster a culture of prejudice against this already vulnerable community.
Continued support from state and federal lawmakers is essential to protecting the rights of all citizens, regardless of gender identity. The principles, on which this act was established, need to be upheld. All Americans deserve freedom, opportunity, and equality.
SITUATION: One of the vulnerable populations in the healthcare setting today is patients at the end of life. These patients may have a terminal illness that has brought them to this point or they may have a disease process where the morbidity rate is high and recovery to a quality life isn’t possible.
BACKGROUND: Despite the advances in technologies in the healthcare environment, not all our patients can be saved. Terminal illness like Cancer is the second leading cause of death in the United States. Other disease processes like Heart disease and Respiratory disease can bring patients to the end of life, when undiagnosed and not treated. And there many others not mentioned.
ASSESSMENT: There are laws developed to assist patients with many healthcare issues. One such law that has multiple state approval but in Congress has only passed the Senate thus far is the Right-to-Try law. The law allows the use of investigational drugs or treatments prior to full FDA approval for terminally ill patients who have exhausted all other efforts. The law fails to address several issues that could result from its passing as it stands now.
RECOMMENDATION: The ethical issues that need to be addressed include: 1) Is it right for a drug that ends up causing harm or death, then be approved by the FDA? According to the law, the FDA can’t use that information in final approval. 2) Is it right to cause a dying patient potential complication from an investigational drug? Financial issues to address: 1) Who pays for the cost of the drug and any complications that arise? Does the patient’s medical coverage alter because of the use of investigational drug use?
As nurses, we need to follow the Code of Ethics in providing patient care.